Search | National Guideline Clearinghouse | “Neoplasms” 1

Search | National Guideline Clearinghouse

1-20 of 23 results for

“Neoplasms”

• GUIDELINE SUMMARY
 
• NGC:010264
 
• 2012 MAR (REVISED 2013 FEB)

Preoperative and pretreatment investigations for malignant melanoma.

CancerControl Alberta

Compare

• GUIDELINE SUMMARY
 
• NGC:009518
 
• 2012 DEC

Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma.

National Institute for Health and Care Excellence (NICE)

Compare

• GUIDELINE SUMMARY
 
• NGC:010262
 
• 2011 FEB (REVISED 2013 FEB)

Optimal excision margins for primary cutaneous melanoma.

CancerControl Alberta

Compare

• GUIDELINE SUMMARY
 
• NGC:009498
 
• 2007 MAY 2 (REVISED 2012 NOV 9)

HealthPartners Dental Group and Clinics oral cancer guideline.

HealthPartners Dental Group

Compare

• GUIDELINE SUMMARY
 
• NGC:010672
 
• 1996 (REVISED 2014)

ACR Appropriateness Criteria® non-spine bone metastases.

American College of Radiology

Compare

• GUIDELINE SUMMARY
 
• NGC:010259
 
• 2010 MAY (REVISED 2013 FEB)

Management of in-transit disease of the limbs.

CancerControl Alberta

Compare

• GUIDELINE SUMMARY
 
• NGC:010248
 
• 2012 MAR (REVISED 2013 FEB)

Biopsy of a suspicious pigmented lesion.

CancerControl Alberta

Compare

• GUIDELINE SUMMARY
 
• NGC:010817
 
• 2015 OCT 7

Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab.

National Institute for Health and Care Excellence (NICE)

Compare

• GUIDELINE SUMMARY
 
• NGC:010571
 
• 2014 OCT

Dabrafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma.

National Institute for Health and Care Excellence (NICE)

Compare

• GUIDELINE SUMMARY
 
• NGC:009678
 
• 1999 (REVISED 2012)

ACR Appropriateness Criteria® single brain metastasis.

American College of Radiology

Compare

• GUIDELINE SUMMARY
 
• NGC:010901
 
• 2016 FEB 10

Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over.

National Guideline Alliance

Compare

• GUIDELINE SUMMARY
 
• NGC:010783
 
• 2015 JUL 29

Melanoma: assessment and management.

National Guideline Alliance

Compare

• GUIDELINE SUMMARY
 
• NGC:010260
 
• 2010 MAY (REVISED 2013 FEB)

Management of resectable stage IV primary cutaneous melanoma without nodal disease.

CancerControl Alberta

Compare

• GUIDELINE SUMMARY
 
• NGC:009517
 
• 2012 DEC

Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma.

National Institute for Health and Care Excellence (NICE)

Compare

• GUIDELINE SUMMARY
 
• NGC:010266
 
• 2011 FEB (REVISED 2013 FEB)

Referral and follow-up surveillance of cutaneous melanoma.

CancerControl Alberta

Compare

• GUIDELINE SUMMARY
 
• NGC:010828
 
• 2015 NOV 11

VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions.

National Institute for Health and Care Excellence (NICE)

Compare

• GUIDELINE SUMMARY
 
• NGC:010882
 
• 2015 AUG

Systemic therapy for unresectable stage III or metastatic cutaneous melanoma.

CancerControl Alberta

Compare

• GUIDELINE SUMMARY
 
• NGC:009838
 
• 2013 MAR

Proton beam radiation therapy.

CancerControl Alberta

Compare

• GUIDELINE SUMMARY
 
• NGC:011023
 
• 2016 JUL 26

Screening for skin cancer: U.S. Preventive Services Task Force recommendation statement.

U.S. Preventive Services Task Force

Compare

• EXPERT COMMENTARY
 

Importance of Quality Metrics for Providing High Quality Melanoma Care

By: Karl Y. Bilimoria, MD, MS